导管治疗时间对急性肺栓塞的结果的影响
Robert S Zhang1, Eugene Yuriditsky2, Peter Zhang3
1Division of Cardiology, Weill Cornell Medicine, New York, NY (R.S.Z.).
Circulation. Cardiovascular interventions
|January 21, 2025
概括
早期以导管为基础的疗法 (CBTs) 显著改善了急性中期风险肺栓塞 (PE) 患者的临床结果. 与延迟治疗相比,这种方法降低了死亡率,心脏骤停和再入院率.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 干预性放射学 干预性放射学
背景情况:
- 急性中等风险肺栓塞 (PE) 带来了重大的临床挑战.
- 干预PE管理的及时性是一个关键因素.
- 导管治疗 (CBT) 提供了对PE的最小侵入性治疗选择.
研究的目的:
- 评估早期与延迟导管治疗 (CBT) 对急性中期风险肺栓塞 (PE) 患者临床结果的影响.
- 确定早期CBT受益的潜在预测因素.
主要方法:
- 追溯队列研究分析了两所学术中心 (2020年1月至2024年1月) 中等风险PE患者的133名患者的数据.
- 患者被分为早期 (<12小时) 和延迟 (≥12小时) 的CBT组.
- 逆治疗概率加权 (IPTW) 用于平衡共变量和评估结果.
主要成果:
- 早期的CBT与延迟的CBT相比 (4%与18%相比;P<0.001) 与主要复合结局 (死亡率,复苏心脏骤停,血液动力学不稳定性,90天再入院) 的显著较低率有关.
- 早期干预也导致了二次综合结果 (死亡率,心脏骤停,血液动力学不稳定性) 的显著减少 (0%与9%相比;P=0.02).
- 早期接受CBT的患者经历了更短的重症监护室 (ICU) 和住院时间.
结论:
- 早期以导管为基础的治疗 (CBT) 在急性中期风险肺栓塞 (PE) 患者中显示出优异的临床结果.
- 复合PE冲击得分可能有助于识别最有可能受益于及时CBT的患者.
- 需要进一步的前性研究来证实这些发现并优化治疗策略.
相关概念视频
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
133
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
133
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170